Xuanyi Li

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 14

Top Topics

Molecular Docking

Transforming Growth Factor

Signaling Pathway

Top Venues

Expert opinion on therapeutic patents

Future medicinal chemistry

Organic letters

This page only lists publications with an associated author ORCID identifier.

Publications

Lingyu Kong, Wenqing Ti, Aijun Lin, Hequan Yao, Yue Huang, Xuanyi Li
Palladium-Catalyzed Defluorinative Alkylation of gem -Difluoroalkenes with Cyclopropanols: Stereoselective Synthesis of γ-Fluorinated γ,δ-Unsaturated Ketones. Organic letters (2024)
Yong Yan, Hanwen Liu, Di Wu, Zhihao Gu, Wenhao Guo, Hequan Yao, Kejiang Lin, Xuanyi Li
Design, synthesis and biological evaluation of novel 3C-like protease inhibitors as lead compounds against SARS-CoV-2. Future medicinal chemistry 16 (9) (2024)
Wenhao Guo, Hanwen Liu, Yong Yan, Di Wu, Hequan Yao, Kejiang Lin, Xuanyi Li
Targeting the TGF-β signaling pathway: an updated patent review (2021-present). Expert opinion on therapeutic patents (2024)
Wenhao Guo, Hanwen Liu, Yong Yan, Di Wu, Hequan Yao, Kejiang Lin, Xuanyi Li
Targeting the TGF-β signaling pathway: an updated patent review (2021-present). Expert opinion on therapeutic patents (2024)
Yong Yan, Hanwen Liu, Di Wu, Zhihao Gu, Wenhao Guo, Hequan Yao, Kejiang Lin, Xuanyi Li
Design, synthesis and biological evaluation of novel 3C-like protease inhibitors as lead compounds against SARS-CoV-2. Future medicinal chemistry 16 (9) (2024)
Wenhao Guo, Hanwen Liu, Yong Yan, Di Wu, Hequan Yao, Kejiang Lin, Xuanyi Li
Targeting the TGF-β signaling pathway: an updated patent review (2021-present). Expert opinion on therapeutic patents 34 (3) (2024)
Yong Yan, Hanwen Liu, Di Wu, Zhihao Gu, Wenhao Guo, Hequan Yao, Kejiang Lin, Xuanyi Li
Design, synthesis and biological evaluation of novel 3C-like protease inhibitors as lead compounds against SARS-CoV-2. Future medicinal chemistry (2024)
Lingyu Kong, Wenqing Ti, Aijun Lin, Hequan Yao, Yue Huang, Xuanyi Li
Palladium-Catalyzed Defluorinative Alkylation of gem -Difluoroalkenes with Cyclopropanols: Stereoselective Synthesis of γ-Fluorinated γ,δ-Unsaturated Ketones. Organic letters 26 (17) (2024)
Yong Yan, Hanwen Liu, Di Wu, Zhihao Gu, Wenhao Guo, Hequan Yao, Kejiang Lin, Xuanyi Li
Design, synthesis and biological evaluation of novel 3C-like protease inhibitors as lead compounds against SARS-CoV-2. Future medicinal chemistry 16 (9) (2024)
Wenhao Guo, Hanwen Liu, Yong Yan, Di Wu, Hequan Yao, Kejiang Lin, Xuanyi Li
Targeting the TGF-β signaling pathway: an updated patent review (2021-present). Expert opinion on therapeutic patents 34 (3) (2024)
Yong Yan, Hanwen Liu, Di Wu, Zhihao Gu, Wenhao Guo, Hequan Yao, Kejiang Lin, Xuanyi Li
Design, synthesis and biological evaluation of novel 3C-like protease inhibitors as lead compounds against SARS-CoV-2. Future medicinal chemistry 16 (9) (2024)
Wenhao Guo, Hanwen Liu, Yong Yan, Di Wu, Hequan Yao, Kejiang Lin, Xuanyi Li
Targeting the TGF-β signaling pathway: an updated patent review (2021-present). Expert opinion on therapeutic patents 34 (3) (2024)
Zhihao Gu, Yong Yan, Hequan Yao, Kejiang Lin, Xuanyi Li
Targeting the LPA1 signaling pathway for fibrosis therapy: a patent review (2010-present). Expert opinion on therapeutic patents 32 (10) (2022)
Xuanyi Li, Ziang Ding, Zixuan Wu, Yinqiu Xu, Hequan Yao, Kejiang Lin
Targeting the TGF-β signaling pathway for fibrosis therapy: a patent review (2015-2020). Expert opinion on therapeutic patents 31 (8) (2021)